Genentech

ACTEMRA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / ACTEMRA – J3262

Manufacturer:

Genentech

Name:

ACTEMRA

HCPCS Code Descriptor:

Injection, tocilizumab, 1 mg

Category:

J Code

HCPCS:

J3262

NDC(s):

50242-0135-01, 50242-0143-01, 50242-0138-01, 50242-0137-01, 50242-0136-01

Primary Type:

Immunology:Anti-TNF

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ACTEMRA is an Immunology:Anti-TNF drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J3262 is aligned to the drug ACTEMRA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/11

HCPCS Effective Date:

1/1/11

HCPCS Short Description:

Tocilizumab injection

Billing and Coding Guide:

https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/ACTEMRA-Billing-Coding-for-IV.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation